Cited by 525Oral health in cancer treatmentChemotherapy-related skin toxicityOral Health Pathology and Treatment

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

Sonis, Stephen T.·2009·Oral Oncology

Abstract

The history of mucositis is as old as radiation- and chemotherapy. Despite being regularly reported and documented as one of the worst side effects of cancer therapy, relatively little was appreciated about the complexities of mucositis' pathogenesis until relatively recently. More frustrating for patients and clinicians, no effective treatment existed. Fortunately, the situation is changing; ongoing research is leading to a comprehensive understanding of the biology of mucositis, which has resulted in the development of novel interventions. While the FDA's approval of palifermin in 2004 was limited to only a small percentage of the at-risk population, the fact that the first registered anti-OM agent derived its efficacy from its pleotropic activities was conceptually demonstrative of the therapeutic potential of drugs that selectively interfere with mucositis' pathogenesis. A number of eclectic molecules, all designed to interfere with pathways that lead to injury are in pre-clinical and clinical development.

Integrity signals

Registry

Crossref · 10.1016/j.oraloncology.2009.08.006

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ROS can mediate the deleterious effects of radiation and contribute to DNA damage and activation of senescence pathways in cells.

    “reactive oxygen species (ROS) can mediate the deleterious effects of radiation and contribute to DNA damage and the activation of senescence pathways in cells (Diehn et al., 2009; Kuilman et al., 2010; Sonis, 2009; Spitz et al., 2004).”
  • mTOR inhibition might ameliorate mucositis by preventing the release of a pro-senescent and pro-inflammatory secretome from normal and irradiated cells.

    “suggesting that mTOR inhibition might also ameliorative mucositis by preventing the release of a pro-senescent and pro-inflammatory secretome from normal and irradiated cells (Sonis, 2009)”
  • Generation of ROS is an important mediator of cellular alterations caused by radiation exposure, including mucositis.

    “The generation of ROS is also an important mediator of the cellular alterations caused by radiation exposure (Diehn et al., 2009; Sonis, 2009; Spitz et al., 2004), including mucositis (Citrin et al., 2010; Cotrim et al., 2007; Cotrim et al., 2005).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sonis, S. T.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Sonis, Stephen T.
Venue
Oral Oncology
Publisher
Elsevier BV
Published
2009-12
Volume
45
Issue
12
Pages
1015-1020
ISSN
1368-8375 (ISSN-L)
OpenAlex
W2145063848
Cited by
525
References
42
Citations by year
2026: 22 · 2025: 37 · 2024: 39 · 2023: 34 · 2022: 35 · 2021: 52 · 2020: 35 · 2019: 30 · 2018: 24 · 2017: 31 · 2016: 28 · 2015: 33 · 2014: 35 · 2013: 30 · 2012: 24
FWCI
2.64
Type
journal article
Language
en
Open access
closed
Locations
  • Oral Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Oral health in cancer treatment
  • Health Sciences › Medicine › Dermatology › Chemotherapy-related skin toxicity
  • Health Sciences › Dentistry › Periodontics › Oral Health Pathology and Treatment
Keywords
oral mucositis, radiation-induced mucositis, chemotherapy-induced mucositis, palifermin, mucositis treatment, cancer treatment side effects, preclinical drug development
MeSH terms
Animals, Drug Therapy, Female, Cricetinae, Head and Neck Neoplasms, Humans, Male, Mouth Mucosa, Radiotherapy, Risk Factors, Stomatitis, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review